Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

What You Need to Know Ahead of Charles River Laboratories' Earnings Release

Wilmington, Massachusetts-based Charles River Laboratories International, Inc. (CRL) provides drug discovery, non-clinical development, and safety testing services. Valued at $9.1 billion by market cap, the company offers animal research models in research and development for new drugs, devices, and therapies, serving pharmaceutical and biotechnology companies, hospitals, and academic institutions worldwide. The pharmaceutical company is expected to announce its fiscal first-quarter earnings for 2026 before the market opens on Thursday, May 7.

Ahead of the event, analysts expect CRL to report a profit of $1.96 per share on a diluted basis, down 16.2% from $2.34 per share in the year-ago quarter. The company has...

Fundamentals

See More
  • Market Capitalization, $K 9,073,006
  • Shares Outstanding, K 49,342
  • Annual Sales, $ 4,015 M
  • Annual Income, $ -144,340 K
  • EBIT $ 580 M
  • EBITDA $ 1,149 M
  • 60-Month Beta 1.61
  • Price/Sales 2.17
  • Price/Cash Flow 8.06
  • Price/Book 2.75

Options Overview Details

View History
  • Implied Volatility 53.64% (-1.17%)
  • Historical Volatility 50.37%
  • IV Percentile 78%
  • IV Rank 51.14%
  • IV High 74.13% on 04/21/25
  • IV Low 32.21% on 06/18/25
  • Expected Move (DTE 25) 19.20 (10.48%)
  • Put/Call Vol Ratio 1.05
  • Today's Volume 43
  • Volume Avg (30-Day) 82
  • Put/Call OI Ratio 0.87
  • Today's Open Interest 4,109
  • Open Int (30-Day) 4,291
  • Expected Range 163.98 to 202.38

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.96
  • Number of Estimates 8
  • High Estimate $2.05
  • Low Estimate $1.91
  • Prior Year $2.34
  • Growth Rate Est. (year over year) -16.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
153.25 +19.71%
on 03/27/26
185.61 -1.16%
on 04/17/26
+29.86 (+19.44%)
since 03/20/26
3-Month
146.33 +25.37%
on 02/18/26
228.39 -19.67%
on 01/22/26
-34.73 (-15.92%)
since 01/20/26
52-Week
99.80 +83.83%
on 04/21/25
228.88 -19.84%
on 01/13/26
+77.41 (+72.99%)
since 04/17/25

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 193.18
2nd Resistance Point 189.40
1st Resistance Point 186.64
Last Price 184.44
1st Support Level 180.09
2nd Support Level 176.31
3rd Support Level 173.55

See More

52-Week High 228.88
Last Price 184.44
Fibonacci 61.8% 179.57
Fibonacci 50% 164.34
Fibonacci 38.2% 149.11
52-Week Low 99.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.